Pharsight

Drugs that contain Morphine Sulfate; Naltrexone Hydrochloride

1. Embeda patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8685443 ALPHARMA PHARMS Sequestering subunit and related compositions and methods
Jul, 2025

(1 year, 4 months from now)

US8685444 ALPHARMA PHARMS Sequestering subunit and related compositions and methods
Jul, 2025

(1 year, 4 months from now)

US8846104 ALPHARMA PHARMS Pharmaceutical compositions for the deterrence and/or prevention of abuse
Jun, 2027

(3 years from now)

US8877247 ALPHARMA PHARMS Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist
Jun, 2027

(3 years from now)

US7682633 ALPHARMA PHARMS Pharmaceutical composition
Jun, 2027

(3 years from now)

US7682634 ALPHARMA PHARMS Pharmaceutical compositions
Jun, 2027

(3 years from now)

US8158156 ALPHARMA PHARMS Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist
Jun, 2027

(3 years from now)

US7815934 ALPHARMA PHARMS Sequestering subunit and related compositions and methods
Dec, 2027

(3 years from now)

US8623418 ALPHARMA PHARMS Pharmaceutical composition
Nov, 2029

(5 years from now)

Market Authorisation Date: 13 August, 2009

Treatment: Management of pain severe enough to require daily, around-the-clock, long term opioid treatment by orally administering a plurality of composite subunits as claimed; Management of pain severe enough t...

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

How can I launch a generic of EMBEDA before it's drug patent expiration?
More Information on Dosage

EMBEDA family patents

Family Patents